Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Tuesday, September 25, 2018 · 463,007,405 Articles · 3+ Million Readers

Russia Healthcare, Regulatory and Reimbursement Market Analysis & Forecast 2022

PUNE, INDIA, April 6, 2018 / -- with their unique quality of simplifying the market research study, presents a deep diving study report “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia”

Healthcare, Regulatory and Reimbursement Landscape - Russia


"Country Focus: Healthcare, Regulatory and Reimbursement Landscape - Russia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Russia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.

Click here for sample report @

Major Highlight of Report

In 2016, Russia population was approximately at 146.9 million. The government of Russia has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country’s future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. Russia’s pharmaceutical market is one of the fastest growing in the world, and the largest in Central and Eastern Europe.

Based on the 2016 currency exchange rate of RUB1 to $0.0165, the market is expected to reach $36.61 billion by 2021. The Russian medical device market was valued at $5.0 billion in 2009 and is one of the most stable industries in the healthcare sector, due to the aging population and consequent increase in demand for healthcare products and services. It grew to $6.7 billion at a CAGR of 4.2% between 2009 and 2016 and is forecast to reach $8.5 billion in 2021. The segments expected to experience high growth are ophthalmic devices, wound care management, CVD, orthopedic devices and diagnostic imaging.


The report provides information on the healthcare, regulatory, and reimbursement landscape in Russia, and includes
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers 
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Sanofi, Bayer, Roche and Pharmstandard) 
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices 
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure 
- An overview of the opportunities for and challenges to growth in the Russian healthcare market


For Detailed Reading Please visit @


About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire